Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
                               
 
The University of Texas at Austin School of Nursing is an approved provider of continuing nursing education by the Texas Nurses Association - Approver, an accredited approver with distinction by the American Nurses Credentialing Center's Commission on Accreditation.
 
 
 
 

Osteoarthritis Management


This CE activity was originally published in The Rx Consultant.  If you received credit for it previously, you cannot receive credit for it again.

Osteoarthritis (OA) – also called degenerative joint disease – is the most common chronic joint condition, affecting about 27 million Americans. The resulting pain, stiffness, and swelling can affect mobility, productivity, and quality of life.

While no treatment has been shown to slow the progression of joint damage, a combination of non-drug interventions and drug therapy can be used to manage symptoms and improve mobility. Resistance exercise, weight loss, and psychosocial interventions are among the non-drug interventions recommended for osteoarthritis patients. Recommended drug therapies include acetaminophen, oral and topical nonsteroidal antiinflammatory drugs (NSAIDs), tramadol, and intra-articular corticosteroid injections. The American College of Rheumatology (ACR) provides recommendations for the management of hand, knee, and hip OA.3 The American Academy of Orthopaedic Surgeons (AAOS) provides somewhat different recommendations for the management of knee and hip OA. Drug therapy recommendations are summarized in the Appendix.

This issue will focus on oral medications and complementary therapies commonly used for the treatment of OA – particularly OA of the knee, hip, and hand – based on ACR and AAOS guidelines,3-5 as well as other evidence-based literature.

Fee

$10.00

CE Hours

1.50

CE Units

0.150

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, and Registered Nurses

Accreditation(s)

This CE activity was developed by The Rx Consultant, a publication of Continuing Education Network, Inc.

CE activities for Pharmacists and Pharmacy Technicians:
This continuing education (CE) activity meets the requirements of all state boards of pharmacy for approved continuing education hours.  CE credit is automatically reported to CPE Monitor.
 
CE activities for Nurse Practitioners and Clinical Nurse Specialists: 
    This continuing education activity meets the requirements of:
        The American Nurses Credentialing Center (ANCC) for formally approved continuing education (CE) hours, and CE hours of pharmacotherapeutics.
        The American Academy of Nurse Practitioners Certification Program (AANPCP) for acceptable, accredited CE.
 
    This is a pharmacotherapeutics/pharmacology CE activity.
  • The ANCC requires all advanced practice nursing certificants (CNSs and NPs) to complete 25 CE hours of pharmacotherapeutics as a portion of the required 75 continuing education hours.
  • Pharmacology CE is recommended by the AANPCP and will be required for Certificants renewing certification starting January 2017.  
  • Most State Boards of Nursing require a minimum number of pharmacy contact hours to renew an advanced practice license.
 
 
Accreditation Council for Pharmacy Education
Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

To receive CE credit, the participant must read the monograph in its entirety, complete the online post-test and receive a score of 70% or greater, and complete the online evaluation.
 
Pharmacists and Pharmacy Technicians -
 
Be sure your profile has been updated with your NAPB e-profile # and birth date information BEFORE completing the online evaluation, or your credits cannot be reported to CPE Monitor.
 
Continuing pharmacy education credit is automatically reported to CPE Monitor once the post-test & evaluation are successfully completed.

 

 

 

Objectives

  • Describe the benefits (or lack of benefit) of nondrug therapies (eg, exercise, physical therapy, weight loss, tai chi, acupuncture) in the management of hip and knee osteoarthritis (OA).
  • Discuss the efficacy and side effect/safety profiles of acetaminophen, NSAIDs (oral and topical), tramadol, capsaicin, and duloxetine. Recommend analgesic therapy for OA based on efficacy and patients’ coexisting conditions.
  • Discuss the potential benefits of complementary and alternative medicine, including the use of supplements, in OA management.

Speaker(s)/Author(s)

Jelena Lewis, PharmD, PharmD
Assistant Professor of Pharmacy Practice, Chapman University School of Pharmacy.


Brief Bio : Jelena Lewis, PharmD is an Assistant Professor of Pharmacy Practice at Chapman University School of Pharmacy. She is also a faculty-in-residence at St. Jude Heritage Medical Group where she provides chronic disease state management. se state management.

Laressa Bethishou, PharmD, BCPS
Assistant Professor of Pharmacy Practice, Chapman University School of Pharmacy

Activity Number

0428-0000-17-010-H01-P

Release Date: Oct 23, 2017
Credit Expiration Date: Oct 23, 2020

CE Hours

1.50

Fee

$10.00
 

The CE Activity developed by The Rx Consultant